Neurodegenerative diseases (NDDs) affect over 50 million globally, posing a growing health and economic burden. Traditional in vivo models have high failure rates in clinical trials. Organ-on-a-chip ...
Library Collection(s)
Neurodegenerative diseases (NDDs) affect over 50 million globally, posing a growing health and economic burden. Traditional in vivo models have high failure rates in clinical trials. Organ-on-a-chip ...